NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Abstract
NMDA receptors (NMDARs) are glutamate-gated ion channels and are crucial for neuronal communication. NMDARs form tetrameric complexes that consist of several homologous subunits. The subunit composition of NMDARs is plastic, resulting in a large number of receptor subtypes. As each receptor subtype has distinct biophysical, pharmacological and signalling properties, there is great interest in determining whether individual subtypes carry out specific functions in the CNS in both normal and pathological conditions. Here, we review the effects of subunit composition on NMDAR properties, synaptic plasticity and cellular mechanisms implicated in neuropsychiatric disorders. Understanding the rules and roles of NMDAR diversity could provide new therapeutic strategies against dysfunctions of glutamatergic transmission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, the GluN2B subunit confers the highest relative Ca2+ permeability among NMDAR subunits while also reducing deactivation rate and open probability”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Paoletti et al., 2013
In the citing paper
“Each of these genes' respective subunits are highest expressed during embryonic and early postnatal stages, and have been associated with the maintenance of immature dendritic spines during development (Paoletti et al., 2013).”
From Glutamate receptors in domestication and modern human evolution (2020) · cites this paper as Paoletti et al., 2013
In the citing paper
“They are permeant to Ca 2+ , which mediates many of the consequences of NMDAR activity, including synaptic modification, learning and memory, activity-dependent development, and neuroprotective/homeostatic signaling [6][7][8] .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [6]
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Genetic enhancement of learning and memory in mice
Tang, Y.-P., Shimizu, E., Dube, G. R., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,863
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Cited by
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
“It is possible that the HNK-induced reduction of intracellular D-serine levels may also result in a reduction of extracellular levels of this amino acid.”
BackgroundInfluentialColucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991
“Activation of L-VGCC and NMDA receptors mediate intracellular Ca2+-signaling and regulate several aspects of brain functions (for review [34,35]).”
BackgroundCalabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05672-9 · Cited by 817
“SPNs were also recently investigated for the first time for detecting early synaptic transmission alterations exerted by α-syn Cell Death and Disease (2023) 14:176 oligomers, combining multiple techniques like electrophysiology optogenetics, immunofluorescence, and molecular and behavioral analyses [106].”
BackgroundInfluentialThe Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017) · Neural Plasticity · doi:10.1155/2017/9724371 · Cited by 775
Neuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748
“The composition of the subunits of NMDARs is plastic, resulting in a large number of receptor subtypes with distinct biophysical, pharmacological, and signaling properties [16].”
BackgroundStructure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability
Vezzani, A., & Viviani, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.027 · Cited by 670
Reiner, A., & Levitz, J. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.018 · Cited by 631
Fiorentini, D., Cappadone, C., Farruggia, G., & Prata, C. (2021) · Nutrients · doi:10.3390/nu13041136 · Cited by 559
“These abilities are involved in the observed effect of magnesium on the cardiovascular system, muscle, and brain; − Neuronal magnesium concentrations downregulate the excitability of the N-methylD-aspartate (NMDA) receptor, which is essential for excitatory synaptic transmission and neuronal plasticity in learning and…”
BackgroundStructure, function, and allosteric modulation of NMDA receptors
Hansen, K. B., Yi, F., Perszyk, R. E., Furukawa, H., Wollmuth, L. P., Gibb, A. J., & Traynelis, S. F. (2018) · Journal of General Physiology · doi:10.1085/jgp.201812032 · Cited by 573
“Among the many differences in functional properties governed by the GluN2 subunit, several are particularly noteworthy (Erreger et al., 2004; Traynelis et al., 2010; Paoletti et al., 2013; Wyllie et al., 2013; Glasgow et al., 2015).”
BackgroundCerebral plasticity: windows of opportunity in the developing brain
Ismail, F. Y., Fatemi, A., & Johnston, M. V. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.07.007 · Cited by 572
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
“The sheer diversity of NMDARs (Paoletti et al., 2013) complicates comparisons of the literature under different experimental conditions and, perhaps not surprisingly, the localization hypothesis remains a controversial topic.”
InfluentialThe Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
“Both co-agonists are of glial origin (Papouin et al., 2012).”
Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516
“As a result, NMDARs exist as multiple subtypes - with each having uniquely physiological and pharmacological properties and are spatially and developmentally regulated and differentially distributed across neuronal subtypes [296].”
BackgroundNMDA receptor structures reveal subunit arrangement and pore architecture
Lee, C.-H., Lü, W., Michel, J. C., Goehring, A., Du, J., Song, X., & Gouaux, E. (2014) · Nature · doi:10.1038/nature13548 · Cited by 520
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
Astrocytes Control Circadian Timekeeping in the Suprachiasmatic Nucleus via Glutamatergic Signaling
Brancaccio, M., Patton, A. P., Chesham, J. E., Maywood, E. S., & Hastings, M. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.030 · Cited by 434
“NMDAR subunit composition varies widely across brain regions, and many areas of the brain express various combinations of the NMDAR1, 2A, 2B, 2C, and 2D subunits (Paoletti et al., 2013).”
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386
“It is in fact likely that every single disorder within the group has its unique mechanisms and consequences, with environmental and genetic factors playing roles in the etiology of ASDs.”
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
“The amino-terminal domain and carboxy-terminal domain regions are the most divergent and account for much of the functional diversity of NMDAR.35 D-serine and glycine bind to GluN1 and GluN3 subunits, which is designated the glycine modulatory site (GMS), and glutamate binds to GluN2 subunits at the glutamine binding…”
BackgroundInfluentialBernardinelli, Y., Randall, J., Janett, E., Nikonenko, I., König, S., Jones, E. V., Flores, C. E., Murai, K. K., Bochet, C. G., Holtmaat, A., et al. (2014) · Current Biology · doi:10.1016/j.cub.2014.06.025 · Cited by 369
“It is largely accepted that a first step is a functional potentiation of synaptic transmission, mainly due to the recruitment of a-amino-3-hydroxy-5-methylisoazol-4-propionate receptor (AMPAR) at postsynaptic spines [43].”
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling
Habbas, S., Santello, M., Becker, D., Stubbe, H., Zappia, G., Liaudet, N., Klaus, F. R., Kollias, G., Fontana, A., Pryce, C. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.023 · Cited by 347
“NR2B antagonists are currently under clinical investigation in several neurologic and psychiatric disorders (Paoletti et al., 2013).”
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
“NMDA receptors assemble as a tetramer requiring two glycine-binding GluN1 subunits and two glutamate-binding GluN2 subunits (Traynelis et al., 2010; Paoletti et al., 2013).”
BackgroundLinking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Hansen, K. B., Ogden, K. K., Yuan, H., & Traynelis, S. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.035 · Cited by 305
“Deactivation time course for GluN1/GluN2A/GluN2B receptors GluN2A and GluN2B subunits play distinct physiological roles in many processes of the central nervous system (Paoletti et al., 2013).”
InfluentialThe NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in Pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285
Neuro-toxic and Reproductive Effects of BPA
Santoro, A., Chianese, R., Troisi, J., Richards, S., Nori, S. L., Fasano, S., Guida, M., Plunk, E., Viggiano, A., Pierantoni, R., et al. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190726112101 · Cited by 278
Dendritic Tau in Alzheimer’s Disease
Ittner, A., & Ittner, L. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.003 · Cited by 278
Mechanism of NMDA receptor channel block by MK-801 and memantine
Song, X., Jensen, M. Ø., Jogini, V., Stein, R. A., Lee, C.-H., Mchaourab, H. S., Shaw, D. E., & Gouaux, E. (2018) · Nature · doi:10.1038/s41586-018-0039-9 · Cited by 264
Detection and analysis of chiral molecules as disease biomarkers
Liu, Y., Wu, Z., Armstrong, D. W., Wolosker, H., & Zheng, Y. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00476-z · Cited by 242
The Emergence of a Circuit Model for Addiction
Lüscher, C. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-013920 · Cited by 260
“Canonical NMDARs are heteromers made from two GluN1 subunits and two GluN2 subunits, which can be of either the 2A or 2B splice variant (Paoletti et al. 2013).”
Platzer, K., Yuan, H., Schütz, H., Winschel, A., Chen, W., Hu, C., Kusumoto, H., Heyne, H. O., Helbig, K. L., Tang, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104509 · Cited by 252
“Three diagnostic WES trio cohorts reported 8051 patients with neurodevelopmental disorders (defined as human phenotype ontology terms (1) abnormality of the nervous system, (2) multiple congenital anomalies, (3) seizures or (4) ASD.”
BackgroundSex differences in glutamate receptor gene expression in major depression and suicide
Gray, A. L., Hyde, T. M., Deep-Soboslay, A., Kleinman, J. E., & Sodhi, M. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.91 · Cited by 250
Neuronal heterogeneity and stereotyped connectivity in the auditory afferent system
Petitpré, C., Wu, H., Sharma, A., Tokarska, A., Fontanet, P., Wang, Y., Helmbacher, F., Yackle, K., Silberberg, G., Hadjab, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06033-3 · Cited by 252
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
Folch, J., Busquets, O., Ettcheto, M., Sánchez-López, E., Castro-Torres, R. D., Verdaguer, E., Garcia, M. L., Olloquequi, J., Casadesús, G., Beas-Zarate, C., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170672 · Cited by 245
“The presence of NFTs, which are intracellular deposits of helical paired filaments composed of abnormally hyperphosphorylated tau protein, is well characterized in AD brains [36–40].”
BackgroundInfluentialPapouin, T., Dunphy, J. M., Tolman, M., Dineley, K. T., & Haydon, P. G. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.021 · Cited by 243
“5 mM) and wakefulness (3 mM), thus nearly spanning the entire range of NMDAR co-agonist site sensitivity (Paoletti et al., 2013).”
InfluentialThe synapse in traumatic brain injury
Jamjoom, A. A. B., Rhodes, J., Andrews, P. J. D., & Grant, S. G. N. (2021) · Brain · doi:10.1093/brain/awaa321 · Cited by 241
“These are ligand-gated ionotropic receptors, which play an important role in synaptic transmission and plasticity (Voglis and Tavernarakis, 2006; Paoletti et al., 2013).”
BackgroundViana da Silva, S., Haberl, M. G., Zhang, P., Bethge, P., Lemos, C., Gonçalves, N., Gorlewicz, A., Malezieux, M., Gonçalves, F. Q., Grosjean, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11915 · Cited by 242
Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke
Shen, Z., Xiang, M., Chen, C., Ding, F., Wang, Y., Shang, C., Xin, L., Zhang, Y., & Cui, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113125 · Cited by 227
Activation of NMDA receptors and the mechanism of inhibition by ifenprodil
Tajima, N., Karakas, E., Grant, T., Simorowski, N., Diaz-Avalos, R., Grigorieff, N., & Furukawa, H. (2016) · Nature · doi:10.1038/nature17679 · Cited by 233
Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
Nagele, P., Duma, A., Kopec, M., Gebara, M. A., Parsoei, A., Walker, M., Janski, A., Panagopoulos, V. N., Cristancho, P., Miller, J. P., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.016 · Cited by 230
Mechanism of NMDA Receptor Inhibition and Activation
Zhu, S., Stein, R. A., Yoshioka, C., Lee, C.-H., Goehring, A., Mchaourab, H. S., & Gouaux, E. (2016) · Cell · doi:10.1016/j.cell.2016.03.028 · Cited by 228
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.010 · Cited by 219
GRIN2A -related disorders: genotype and functional consequence predict phenotype
Strehlow, V., Heyne, H. O., Vlaskamp, D. R. M., Marwick, K. F. M., Rudolf, G., de Bellescize, J., Biskup, S., Brilstra, E. H., Brouwer, O. F., Callenbach, P. M. C., et al. (2019) · Brain · doi:10.1093/brain/awy304 · Cited by 220
“NMDAR containing GluN2B have slower deactivation times than those containing GluN2A (Paoletti et al., 2013; Wyllie et al., 2013).”
BackgroundMolecular mechanisms of ischemia and glutamate excitotoxicity
Neves, D., Salazar, I. L., Almeida, R. D., & Silva, R. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121814 · Cited by 214
Structural basis of ketamine action on human NMDA receptors
Zhang, Y., Ye, F., Zhang, T., Lv, S., Zhou, L., Du, D., Lin, H., Guo, F., Luo, C., & Zhu, S. (2021) · Nature · doi:10.1038/s41586-021-03769-9 · Cited by 218
Emerging roles of GluN3-containing NMDA receptors in the CNS
Pérez-Otaño, I., Larsen, R. S., & Wesseling, J. F. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.92 · Cited by 214
Zinc Dynamics and Action at Excitatory Synapses
Vergnano, A. M., Rebola, N., Savtchenko, L. P., Pinheiro, P. S., Casado, M., Kieffer, B. L., Rusakov, D. A., Mulle, C., & Paoletti, P. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.034 · Cited by 213
Self-citationGRIN2B mutations in west syndrome and intellectual disability with focal epilepsy
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., Pepler, A., Steiner, I., Hörtnagel, K., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24073 · Cited by 212
“NMDA receptors are tetrameric ligand-gated ion channels permeable to Na(1), K(1), and Ca(21), composed of 2 glycine-binding NR1 subunits and 2 glutamate-binding NR2 subunits (NR2A, NR2B, NR2C, NR2D).(25,26) Subunit composition of NMDA receptors is spatially and temporally regulated with a switch from predominant NR2B…”
BackgroundNMDA Receptors in the Central Nervous System
Hansen, K. B., Yi, F., Perszyk, R. E., Menniti, F. S., & Traynelis, S. F. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7321-7_1 · Cited by 199
“Given the central roles of NMDA receptors in normal brain function, it is not surprising that their dysregulation has been linked to a number of pathophysiological conditions [2,1,42,23].”
BackgroundInfluentialIonotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases
Yuan, H., Low, C.-M., Moody, O. A., Jenkins, A., & Traynelis, S. F. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.097998 · Cited by 205
“receptors that can be divided into three subtypes [a-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainate, and N-methyl-D-aspartate (NMDA)] on the basis of pharmacology and structure (Traynelis et al., 2010; Paoletti et al., 2013).”
BackgroundDelineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy
Lemke, J. R., Geider, K., Helbig, K. L., Heyne, H. O., Schütz, H., Hentschel, J., Courage, C., Depienne, C., Nava, C., Heron, D., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002740 · Cited by 200
Toxoplasma gondii‐induced neuronal alterations
Parlog, A., Schlüter, D., & Dunay, I. R. (2015) · Parasite Immunology · doi:10.1111/pim.12157 · Cited by 201
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Ambrosi, G., Cerri, S., & Blandini, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1149-z · Cited by 195
“NR2B) (Paoletti et al. 2013) or would be able to selectively interact with the pathways downstream of NMDARs activation,to prevent the intracellular responses that mediate excitotoxicity and eventually neuronal death (i.”
BackgroundNMDA receptor subunit mutations in neurodevelopmental disorders
Burnashev, N., & Szepetowski, P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.008 · Cited by 197
NMDA receptor dysfunction in autism spectrum disorders
Lee, E.-J., Choi, S. Y., & Kim, E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.007 · Cited by 192
“Regarding the second question, one straightforward possibility is that NMDAR dysfunction may impact neuronal or synaptic development, or NMDAR-dependent synaptic transmission or plasticity in mature neurons [14].”
BackgroundPham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
“NMDA-Rs are mobile (at least in cultured neurons), particularly the GluN2B-containing ones, and probably exchange through lateral diffusion between synaptic and extrasynaptic sites (Paoletti et al., 2013).”
BackgroundRecent genetic findings in schizophrenia and their therapeutic relevance
Harrison, P. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114553647 · Cited by 183
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Latypova, X., Towne, M. C., Cho, M. T., Prescott, T. E., Ploeg, M. A., Sanders, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.003 · Cited by 185
Neuronal SUMOylation: Mechanisms, Physiology, and Roles in Neuronal Dysfunction
Henley, J. M., Craig, T. J., & Wilkinson, K. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00008.2014 · Cited by 182
“NMDARs require both agonist activation and membrane depolarization to remove an intracellular channel block by Mg(2) to allow Ca(2) gating (200).”
BackgroundTemido-Ferreira, M., Ferreira, D. G., Batalha, V. L., Marques-Morgado, I., Coelho, J. E., Pereira, P., Gomes, R., Pinto, A., Carvalho, S., Canas, P. M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0110-9 · Cited by 179
“observed for GluN1/GluN2A heteromers [56].”
Acute and chronic effects of ethanol on learning-related synaptic plasticity
Zorumski, C. F., Mennerick, S., & Izumi, Y. (2014) · Alcohol · doi:10.1016/j.alcohol.2013.09.045 · Cited by 172
“synapses, and this has implications for interpreting the effects of subtype selective antagonists (Paoletti et al., 2013).”
BackgroundCryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation
Lü, W., Du, J., Goehring, A., & Gouaux, E. (2017) · Science · doi:10.1126/science.aal3729 · Cited by 176
The developmental stages of synaptic plasticity
Lohmann, C., & Kessels, H. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2012.235119 · Cited by 180
“D, which are differentially expressed across brain regions and developmental stages (Cull-Candy et al. 2001; Paoletti et al. 2013).”
BackgroundSwanger, S. A., Chen, W., Wells, G., Burger, P. B., Tankovic, A., Bhattacharya, S., Strong, K. L., Hu, C., Kusumoto, H., Zhang, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.10.002 · Cited by 178
How the epigenome integrates information and reshapes the synapse
Campbell, R. R., & Wood, M. A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0121-9 · Cited by 173
Hackos, D. H., Lupardus, P. J., Grand, T., Chen, Y., Wang, T.-M., Reynen, P., Gustafson, A., Wallweber, H. J. A., Volgraf, M., Sellers, B. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.016 · Cited by 177
Self-citationOrganization, control and function of extrasynaptic NMDA receptors
Papouin, T., & Oliet, S. H. R. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0601 · Cited by 171
Physiological Roles of Non-Neuronal NMDA Receptors
Hogan-Cann, A. D., & Anderson, C. M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.012 · Cited by 173
NMDA receptor functions in health and disease: Old actor, new dimensions
Dupuis, J. P., Nicole, O., & Groc, L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.002 · Cited by 172
Circuit and Synaptic Plasticity Mechanisms of Drug Relapse
Dong, Y., Taylor, J. R., Wolf, M. E., & Shaham, Y. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1821-17.2017 · Cited by 169
“The presence of GluN3 subunits endows NMDARs with atypical properties, namely low sensitivity to Mg 2 block, low Ca 2 permeability, and lower conductance (Cull-Candy and Leszkiewicz, 2004; Henson et al., 2010; Pachernegg et al., 2012; Paoletti et al., 2013).”
BackgroundMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Frank, R. A. W., Komiyama, N. H., Ryan, T. J., Zhu, F., O’Dell, T. J., & Grant, S. G. N. (2016) · Nature Communications · doi:10.1038/ncomms11264 · Cited by 166
Allosteric modulators of NMDA receptors: multiple sites and mechanisms
Zhu, S., & Paoletti, P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.009 · Cited by 170
“NMDARs have also triggered intense interest as potential drug targets because their dysregulation, both hyper-activation and hypo-activation, has been implicated in a wide range of neurological and psychiatric disorders including pathological pain, epilepsy, Alzheimer’s disease, schizophrenia, depression and mental re…”
BackgroundInfluentialSelf-citationYu, S. P., Jiang, M. Q., Shim, S. S., Pourkhodadad, S., & Wei, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00636-1 · Cited by 189
Dynamical consequences of regional heterogeneity in the brain’s transcriptional landscape
Deco, G., Kringelbach, M. L., Arnatkeviciute, A., Oldham, S., Sabaroedin, K., Rogasch, N. C., Aquino, K. M., & Fornito, A. (2021) · Science Advances · doi:10.1126/sciadv.abf4752 · Cited by 164
Bukke, V. N., Archana, M., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 161
Infantile amnesia reflects a developmental critical period for hippocampal learning
Travaglia, A., Bisaz, R., Sweet, E. S., Blitzer, R. D., & Alberini, C. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4348 · Cited by 159
“In line with previous data 25, 26 , we found that NMDARs significantly switch their subunit expression levels during postnatal development, going from an elevated expression ratio in favor of GluN2B to predominately expressing GluN2A (Fig.”
Bading, H. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161673 · Cited by 170
“Synaptic NMDA receptors initiate physiological changes in the efficacy of synaptic transmission (Petralia et al., 2010; Morris, 2013; Paoletti et al., 2013).”
BackgroundInfluentialCanitano, R., & Pallagrosi, M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00069 · Cited by 179
Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants
Yan, J., Bengtson, C. P., Buchthal, B., Hagenston, A. M., & Bading, H. (2020) · Science · doi:10.1126/science.aay3302 · Cited by 159
Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.25 · Cited by 154
“Thus, in addition to the direct effects of cytokines on glutamate metabolism, decreased availability of dopamine may indirectly lead to an overactivation of glutamatergic projections to the striatum and basal ganglia output nuclei as seen in PD (Hallett and Standaert, 2004; Paoletti et al, 2013).”
BackgroundTörök, N., Tanaka, M., & Vécsei, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249338 · Cited by 156
“plasticity of learning, memory, and other aspects of cognition [14-17].”
Gunn, B. G., Cunningham, L., Cooper, M. A., Corteen, N. L., Seifi, M., Swinny, J. D., Lambert, J. J., & Belelli, D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1337-13.2013 · Cited by 151
“Next, we explored possible additional alterations in glutamatergic transmission mediated by extrasynaptic receptors (Groc et al., 2009; Paoletti et al., 2013).”
BackgroundRegulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
“…display striking differences in their spatiotemporal expression patterns in the brain, as well as unique pharmacological and functional properties (Monyer, Burnashev, Laurie, Sakmann, & Seeburg, 1994; Sheng et al., 1994; Hansen, Yi, Perszyk, Menniti, & Traynelis, 2017; Paoletti et al., 2013).”
BackgroundStim and Orai proteins in neuronal Ca2+ signaling and excitability
Moccia, F. D., Zuccolo, E., Soda, T., Tanzi, F., Guerra, G., Mapelli, L., Lodola, F., & D'Angelo, E. U. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00153 · Cited by 153
“Consistent with these observations, co-expressing Orai1 with Stim1 causes a statistically relevant elevation in SOCE, whereas transfecting the neurons with Orai1 and Stim2 enhances both constitutive Ca2+ influx and resting Ca2+ levels (Gruszczynska-Biegala et al., 2011).”
BackgroundInfluentialNMDA and AMPA receptors dysregulation in Alzheimer's disease
Babaei, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174310 · Cited by 161
Presynaptic Spike Timing-Dependent Long-Term Depression in the Mouse Hippocampus
Andrade‐Talavera, Y., Duque‐Feria, P., Paulsen, O., & Moreno, A. R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw172 · Cited by 166
“GluN3A subunit-containing presynaptic NMDA receptors are required for t-LTD in themouse visual cortex during development (Larsen et al. 2011), and di-heteromeric GluN1/GluN3A NMDA receptors without glutamate-binding sites have been suggested to exist (Paoletti et al. 2013).”
BackgroundDistinct roles of GRIN2A and GRIN2B variants in neurological conditions
Myers, S. J., Yuan, H., Kang, J., Tan, F. C. K., Traynelis, S. F., & Low, C. (2019) · F1000Research · doi:10.12688/f1000research.18949.1 · Cited by 161
Glycine: The Smallest Anti-Inflammatory Micronutrient
Aguayo-Cerón, K. A., Sánchez‐Muñoz, F., Gutiérrez-Rojas, R. A., Acevedo-Villavicencio, L. N., Flores-Zarate, A. V., Huang, F., Giacoman‐Martínez, A., Villafaña, S., & Romero‐Nava, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411236 · Cited by 159
“Currently, eight splice variants of the GluN1 gene, four GluN2 genes (GluN2A–GluN2AD), and two GluN3 genes (GluN3A and GluN3B) have been identified [54].”
BackgroundChimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
Reincke, S. M., von Wardenburg, N., Homeyer, M. A., Kornau, H., Spagni, G., Li, L. Y., Kreye, J., Sánchez-Sendín, E., Blumenau, S., Stappert, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.10.001 · Cited by 162
Microglia Participate in Neurogenic Regulation of Hypertension
Shen, X. Z., Li, Y., Li, L., Shah, K. H., Bernstein, K. E., Lyden, P. D., & Shi, P. D. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05333 · Cited by 154
“Kinase-mediated phosphorylation directly changes the activity and density of NMDA receptor subunits on the membrane.(27) We found that the expression of the NMDA receptor in the PVN was significantly upregulated in the presence of microglia but was decreased when microglia were depleted, suggesting that activated micr…”
BackgroundInfluentialJézéquel, J., Johansson, E. M., Dupuis, J. P., Rogemond, V., Gréa, H., Kellermayer, B., Hamdani, N., Guen, E. L., Rabu, C., Lepleux, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01700-3 · Cited by 161
Unconventional NMDA Receptor Signaling
Doré, K., Stein, I. S., Brock, J. A., Castillo, P. E., Zito, K., & Sjöström, P. J. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1825-17.2017 · Cited by 152
“NMDARs consist of a tetrameric subunit structure, conventionally comprised of two GluN1 and two GluN2 subunits that confer Ca(2) permeability and Mg(2) sensitivity (Traynelis et al., 2010; Paoletti et al., 2013; Iacobucci and Popescu, 2017).”
BackgroundInfluentialBail, M. L., Martineau, M., Sacchi, S., Yatsenko, N., Radzishevsky, I. S., Conrod, S., Ouares, K. A., Wolosker, H., Pollegioni, L., Billard, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416668112 · Cited by 158
“(B) Average traces (Top) for NMDA-fEPSP obtained in each condition (Ctrl: 1), CBIO (2), and D-AP5 (3) are displayed.”
BackgroundMethodInfluentialNMDA receptors: linking physiological output to biophysical operation
Iacobucci, G. J., & Popescu, G. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.24 · Cited by 166
Triheteromeric NMDA receptors: from structure to synaptic physiology
Stroebel, D., Casado, M., & Paoletti, P. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.12.004 · Cited by 166
“A compelling body of evidence shows that triheteromers are widespread in the CNS and represent a significant proportion, if not the majority, of native NMDARs [3].”
BackgroundSelf-citationMolecular bases of NMDA receptor subtype‐dependent properties
Glasgow, N. G., Retchless, B. S., & Johnson, J. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273763 · Cited by 165
“Despite in-depth characterization of NMDAR subtype-dependent properties (for comprehensive reviews see Cull-Candy & Leszkiewicz, 2004; Traynelis et al. 2010; Paoletti et al. 2013), for many of these properties little was known about the mechanisms that underlie their subtype dependence until recently.”
Background
Metadata
- Authors
- Paoletti, P., Bellone, C., & Zhou, Q.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Geneva (CH)
- Genentech (US)
- Corresponding author
- Paoletti, Pierre
- Venue
- Nature Reviews Neuroscience
- Published
- 2013-05-20
- Volume
- 14
- Issue
- 6
- Pages
- 383-400
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2024380057
- Cited by
- 2,523
- References
- 200
- Citations by year
- 2026: 167 · 2025: 202 · 2024: 217 · 2023: 212 · 2022: 217 · 2021: 239 · 2020: 211 · 2019: 191 · 2018: 206 · 2017: 192 · 2016: 170 · 2015: 126 · 2014: 130 · 2013: 42
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- NMDA receptor, receptor subunit composition, synaptic plasticity, glutamatergic neurotransmission, neuropsychiatric disorders, ion channel properties, receptor signaling, NMDA receptor subtypes, therapeutic targeting
- MeSH terms
- Animals, Mental Disorders, Humans, Models, Biological, Neuronal Plasticity, Signal Transduction, Receptors, N-Methyl-D-Aspartate, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.